Most Recent
Sanofi loses challenge to Amgen patents for cholesterol-busting Repatha
Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.